Stockscreener 앱 받기
1.23
4.65%
-0.06
시간 외 거래:
1.25
0.02
+1.63%
전일 마감가:
$1.29
열려 있는:
$1.28
하루 거래량:
251.05K
Relative Volume:
0.10
시가총액:
$13.08M
수익:
-
순이익/손실:
$-39.14M
주가수익비율:
-0.206
EPS:
-5.97
순현금흐름:
$-28.20M
1주 성능:
-4.65%
1개월 성능:
-36.43%
6개월 성능:
-53.93%
1년 성능:
-94.47%
1일 변동 폭
$1.21
$1.3129
1주일 범위
$1.21
$1.425
52주 변동 폭
$0.65
$23.22
Citius Pharmaceuticals Inc Stock (CTXR) Company Profile
명칭
Citius Pharmaceuticals Inc
전화
(908) 967-6676
주소
11 COMMERCE DRIVE, CRANFORD, NJ
CTXR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTXR
Citius Pharmaceuticals Inc
|
1.23 | 14.30M | 0 | -39.14M | -28.20M | -5.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-30 | 업그레이드 | D. Boral Capital | Hold → Buy |
| 2021-11-30 | 개시 | Maxim Group | Buy |
Citius Pharmaceuticals Inc 주식(CTXR)의 최신 뉴스
Citius CTXR 2025Q3 Earnings Preview Upside Ahead on Potential New Product Launch - AInvest
Published on: 2025-08-04 16:39:39 - beatles.ru
Published on: 2025-08-04 09:23:45 - beatles.ru
What is the dividend policy of Citius Pharmaceuticals Inc. stockMaximize your gains with expert trading tips - Jammu Links News
When is Citius Pharmaceuticals Inc. stock expected to show significant growthSpectacular growth rates - Jammu Links News
What are Citius Pharmaceuticals Inc. company’s key revenue driversUnstoppable trading performance - Jammu Links News
What institutional investors are buying Citius Pharmaceuticals Inc. stockAchieve breakthrough investment performance - Jammu Links News
Is Citius Pharmaceuticals Inc. a good long term investmentExceptional ROI - Jammu Links News
Why is Citius Pharmaceuticals Inc. stock attracting strong analyst attentionExceptional trading performance - Jammu Links News
What makes Citius Pharmaceuticals Inc. stock price move sharplyTrack stocks with high upside potential easily - Jammu Links News
How many analysts rate Citius Pharmaceuticals Inc. as a “Buy”Accelerated investment success - Jammu Links News
How does Citius Pharmaceuticals Inc. compare to its industry peersFree Stock Watchlist For Fast Growth - Jammu Links News
What are the technical indicators suggesting about Citius Pharmaceuticals Inc.Chart Pattern Trend Scanner With Low Risk - Jammu Links News
What is Citius Pharmaceuticals Inc. company’s growth strategyRetirement Planning Review With Proven Results - Jammu Links News
Is Citius Pharmaceuticals Inc. reversing from oversold territoryIntraday Trend Analysis for Fast Gains Released - metal.it
Citius Pharmaceuticals Inc. Chart Enters High Volatility ZoneCommunity Entry Consensus Trade Ideas Shared - metal.it
Wyckoff Accumulation Phase Possible in Citius Pharmaceuticals Inc.Weekly Chart Analysis With Entry Advice Provided - metal.it
Is Citius Pharmaceuticals Inc. stock overvalued or undervaluedRapid portfolio appreciation - Jammu Links News
Is it the right time to buy Citius Pharmaceuticals Inc. stockBuild wealth steadily with expert advice - Jammu Links News
What is the risk reward ratio of investing in Citius Pharmaceuticals Inc. stockBreakout profit opportunities - Jammu Links News
What are analysts’ price targets for Citius Pharmaceuticals Inc. in the next 12 monthsDiscover breakthrough stocks with expert help - Jammu Links News
How Citius Pharmaceuticals Inc. stock performs during market volatilityFree Stock Trading Signals - metal.it
What analysts say about Citius Pharmaceuticals Inc. stockFree Investment Community - printweek.in
Citius Pharmaceuticals Inc. Stock Analysis and ForecastLightning-fast growth - Autocar Professional
Citius Oncology Announces Closing of $9.0 Million Public Offering - StreetInsider
What drives Citius Pharmaceuticals Inc. stock priceSuperior risk-adjusted returns - jammulinksnews.com
Citius Pharmaceuticals Inc (CTXR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):